Sector
Israeli drug delivery startups
1 Israeli drug delivery startup is in the directory, with 1 publicly reported funding round totalling $18M. The most recent was Undecimal Bio’s Seed round on Oct 13, 2026.
- Companies
- 1
- Funding rounds
- 1
- Raised
- $18M
- Latest round
- Oct 13, 2026
Companies
| Undecimal BioAI-enabled platform for delivering RNA interference medicines to specific cell types; spun out of Eleven Therapeutics. | Cambridge and Tel Aviv | Oct 13, 2026Seed | $18M |
Most active drug delivery investors
| 1 | 4BIO Capital | 1 | 1 | $18M |
| 2 | IQ Capital | 1 | 1 | $18M |
| 3 | Entree Capital | 1 | 0 | $18M |
| 4 | Harel Tech | 1 | 0 | $18M |
| 5 | Kerna Ventures | 1 | 0 | $18M |
| 6 | Saras Capital | 1 | 0 | $18M |
| 7 | Verve Ventures | 1 | 0 | $18M |
How many Israeli drug delivery startups are there?
1 Israeli drug delivery company has at least one funding round verified against a public report in this directory. Companies without a reported round are not counted.
How much have Israeli drug delivery startups raised?
Rounds with a disclosed amount total $18M across 1 round. Undisclosed rounds are not included in the total.
Which Israeli drug delivery startups raised money most recently?
The latest reported rounds were raised by Undecimal Bio.
Who invests most in Israeli drug delivery startups?
By number of rounds joined: 4BIO Capital (1 round), IQ Capital (1 round) and Entree Capital (1 round).